ArticleScientific reports2025
Assessment of hybrid nanocomposite AFOs for pediatric cerebral palsy: mechanical, spectroscopic, and finite element analysis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cerebral Palsy (CP) is a neurological disorder that affects motor function and causes gait abnormalities in children. Ankle-Foot Orthoses (AFOs) are external aiding devices that provide stability and improve mobility for pediatrics. However, conventional AFO materials often fail to achieve an optimal balance of strength, flexibility, and energy absorption for dynamic movements. This study introduces a novel composite material for pediatric ankle-foot orthoses (AFOs), based on Orthocryl and reinforced with multi-walled carbon nanotubes (MWCNTs) and polylactic acid (PLA). The proposed formulation is engineered to overcome the limitations of conventional materials by providing enhanced mechanical performance and improved functional suitability for clinical applications. Four composite concentrations were fabricated: pure Orthocryl, 0.5% MWCNTs, 0.5% MWCNTs/1.0% PLA, and 0.5% MWCNTs/1.5% PLA. Mechanical and morphological characterizations were performed using a universal testing machine for tensile, flexural, and impact testing, Fourier Transform Infrared Spectroscopy (FT-IR) for material composition analysis, and Field Emission Scanning Electron Microscopy (FE-SEM) for surface morphology examination. To simulate practical application, Finite Element Analysis was performed using ANSYS software, recognizing gait loading conditions. The experimental findings demonstrated that incorporating 0.5% MWCNT into Orthocryl significantly enhanced its mechanical properties, with a 12.5% increase in tensile strength (from 52.79 to 59.4 MPa), a 59.3% increase in flexural strength (from 52.08 to 82.93 MPa), and a 22% improvement in impact resistance (from 28.12 to 34.3 kJ/m
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.